LSAE Publication Sources Tool

Jean SS, Lu MC, Shi ZY, Tseng SH, Wu TS, Lu PL, Shao PL, Ko WC, Wang FD, Hsueh PR. In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infect. 2018; 11: 1983-92.

Biedenbach DJ, Badal RE, Huang MY, Motyl M, Singhal PK, Kozlov RS, Roman AD, Marcella S. In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. Infect Dis Ther. 2016; 5(2): 139-53.

Qadri SM, Ueno Y, Almodovar E. In vitro activity of sparfloxacin against Salmonella typhi. Chemotherapy. 1997; 43(1): 6-9.

Mohamed NM, Youssef AA. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microb Drug Resist. 2011; 17(4): 489-95.

Mohamed NM, Youssef AA. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microb Drug Resist. 2011; 17(4): 489-95.

Lesmana M, Lebron CI, Taslim D, Tjaniadi P, Subekti D, Wasfy MO, Campbell JR, Oyofo BA. In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. Antimicrob Agents Chemother. 2001; 45(1): 359-62.

Roland RK, Mendes RE, Silbert S, Bolsoni AP, Sader HS. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams. Braz J Infect Dis. 2000; 4(5): 226-35.

Malik N, Ahmed M. In vitro effect of new antibiotics against clinical isolates of Salmonella Typhi. J Coll Physicians Surg Pak. 2016; 26(4): 288-92.

Bakthavatchalam YD, Kumar DT, Tayubi IA, Shankar BA, Babu P, Munusamy E, Thukkaram B, Ravi R, Doss CGP, Veeraraghavan B. In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. J Appl Microbiol. 2017; 123(3): 615-24.

Kiliç H, Karahan M. In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics. Mikrobiyol Bul. 1991; 25(1): 28-35.

Berron S, Vazquez JA, Gimenez MJ, e la Fuente L, Aguilar L. In vitro susceptibilities of 400 Spanish isolates of Neisseria gonorrhoeae to gemifloxacin and 11 other antimicrobial agents. Antimicrob Agents Chemother. 2000; 44(9): 2543-4.

Dorlencourt F, Boireaux C, Sednaoui P, Danilenko NV, Legros D. In vitro susceptibility of 120 strains of Neisseria gonorrhoeae isolated in Kyrghyzstan. Sex Transm Dis. 2002; 29(7): 376-8.

Furuya R, Nakayama H, Kanayama A, Saika T, Iyoda T, Tatewaki M, Matsuzaki K, Kobayashi I, Tanaka M. In vitro synergistic effects of double combinations of -lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother. 2006; 12(4): 172-6.

Ekundayo E, Ndubuisi R. In-vitro antimicrobial susceptibility pattern of Staphylococcus aureus isolates in Umuahia, Abia state, Nigeria. Afr J Clin Exp Microbiol. 2015; 16: 62.

Raya S, Belbase A, Dhakal L, Govinda Prajapati K, Baidya R, Kishor Bimali N. In-Vitro Biofilm Formation and Antimicrobial Resistance of Escherichia coli in Diabetic and Nondiabetic Patients. Biomed Res Int. 2019; 2019(1): 1474578.

Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry. Stroke. 2009; 40(2): 394-9.

Smolina K, Wright FL, Rayner M, Goldacre MJ. Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study. Eur J Public Health. 2012; 22(6): 848-53.

Olowo-okere A, Atata R, Abass A, Suleiman S, Shuaibu U, Ungokore H, Nuhu T. Incidence and Antibiotic Susceptibility Profile of Staphylococcus aureus Isolates from Wounds of Patients at Specialist Hospital, Sokoto, Nigeria. J Med Bacteriol. 2017; 6: 44-50.

Olowo-okere A, Atata R, Abass A, Suleiman S, Shuaibu U, Ungokore H, Nuhu T. Incidence and Antibiotic Susceptibility Profile of Staphylococcus aureus Isolates from Wounds of Patients at Specialist Hospital, Sokoto, Nigeria. J Med Bacteriol. 2017; 6: 44-50.

Abdullahi M. Incidence and antimicrobial susceptibility pattern of Salmonella species in children attending some hospitals in Kano Metropolis, Kano State-Nigeria. Bayero J Pure Appl Sci. 2010; 3(1): 202-6.

Sienkiewicz-Jarosz H, Gluszkiewicz M, Pniewski J, Niewada M, Czlonkowska A, Wolfe C, Ryglewicz D. Incidence and case fatality rates of first-ever stroke - comparison of data from two prospective population-based studies conducted in Warsaw. Neurol Neurochir Pol. 2011; 45(3): 207-12.

Corbin DOC, Poddar V, Hennis A, Gaskin A, Rambarat C, Wilks R, Wolfe CDA, Fraser HS. Incidence and Case Fatality Rates of First-Ever Stroke in a Black Caribbean Population: The Barbados Register of Strokes. Stroke. 2004; 35(6): 1254-8.

Kulesh SD, Filina NA, Frantava NM, Zhytko NL, Kastsinevich TM, Kliatskova LA, Shumskas MS, Hilz MJ, Schwab S, Kolominsky-Rabas PL. Incidence and Case-Fatality of Stroke on the East Border of the European Union The Grodno Stroke Study. Stroke. 2010; 41(12): 2726-30.

Nielsen MV, Sarpong N, Krumkamp R, Dekker D, Loag W, Amemasor S, Agyekum A, Marks F, Huenger F, Krefis AC, Hagen RM, Adu-Sarkodie Y, May J, Schwarz NG. Incidence and Characteristics of Bacteremia among Children in Rural Ghana. PLoS One. 2012; 7(9): e44063.

Nielsen MV, Sarpong N, Krumkamp R, Dekker D, Loag W, Amemasor S, Agyekum A, Marks F, Huenger F, Krefis AC, Hagen RM, Adu-Sarkodie Y, May J, Schwarz NG. Incidence and Characteristics of Bacteremia among Children in Rural Ghana. PLoS One. 2012; 7(9): e44063.